| Study | Country Study period Study design |
Data source | Exposure definition | Non-exposure definition | Exposition period | Sample size (exposed/unexposed) Or (case / control) |
Remarks | Risk of bias |
|---|---|---|---|---|---|---|---|---|
|
Chintamaneni 2018 |
USA 2003 - 2014 retrospective cohort (claims database) |
The Kaiser Permanente Southern California Region, USA. | Pregnant women exposed to Lisinopril during pregnancy. |
unexposed (general population or NOS)
Pregnant women not exposed to angiotensin-converting enzyme inhibitors (Ace-i) during pregnancy. |
during pregnancy (anytime or not specified) | 404 / 378834 | Results provided for 'Angiotensin-converting enzyme inhibitors (Ace-i)' as a whole. But as lisinopril represents almost all of the exposures (n=398, 98%), it was considered as equivalent. | |
| Pregnant women exposed to angiotensin-converting enzyme inhibitors (Ace-i) during pregnancy were identified using pharmacy dispensing records. | ||||||||
| Study | Country Study period Study design |
Data source | Case | Control | Exposition | Exposition period | Sample size (exposed/unexposed) Or (case / control) |
Remarks | Risk of bias |
|---|
Risk of bias: : NA; : low; : moderate; : serious; : critical; : unclear;